From August 29, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.73 CNY | -0.87% | -3.31% | -7.10% |
05-14 | Yifan Pharmaceutical Unit Gets Authorization to Sell Circulation Supplement in Singapore | MT |
04-25 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.10% | 2.33B | |
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- 002019 Stock
- News Yifan Pharmaceutical Co., Ltd.
- Tranche Update on Yifan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 31, 2023.